PFOCUS.NS(PFOCUS.NS)

PFOCUS.NS

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

No data available

Next earnings: May 25, 2026

Signal

Mixed1↑1↓

Price

1↓

Move↓-1.96%Negative session

Volume

1→

Volume↓0.1× avgLight volume

Technical

1↑

Trend↑Full UptrendAbove 50D & 200D

PRICE

Prev Close

314.30

Open

313.00

Day Range307.05 – 317.40

307.05

317.40

52W Range92.01 – 367.00

92.01

367.00

79% of range

VOLUME & SIZE

Avg Volume

4.7M

Float

355.8M

FUNDAMENTALS

P/E Ratio

-68.2x

Not profitable

EPS (TTM)

$-4.52

Div Yield

No dividend

Quick Read

Earnings in 23d · May 25

Trend

UPTREND

Price above SMA50 & SMA200

Momentum

BULLISH

price above key MAs · revenue +22% YoY

Valuation

FAIR

P/E not available

Health

WEAK

CR 0.7 (low) · FCF $0.53/sh

Trend

Momentum

Valuation

Health

Bullish

Composite signal across trend, momentum, valuation & healthSignals from latest available data

Key MetricsTTM

Market Cap$109.64B

Revenue TTM$41.79B

Net Income TTM-$945.72M

Free Cash Flow$327.35M

Gross Margin94.2%

Net Margin-2.3%

Operating Margin14.7%

Return on Equity-6.5%

Return on Assets-1.0%

Debt / Equity3.02

Current Ratio0.66

EPS TTM$-1.53

Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar

1 watch5 concern

12/100

Liquidity

0.66Concern

Leverage

3.02Concern

Coverage

1.2xConcern

ROE

-6.5%Concern

ROIC

8.1%Watch

Cash

$2.1BConcern

Analyst Coverage

No analyst coverage available for this stock.

Stock Health

Composite Score

4 of 5 signals bullish

8/10

Trend

●

Trend StateUptrend (price above both MAs)

✓

●

Above SMA 50$302.56 (+1.8%)

✓

●

Above SMA 200$220.20 (+39.9%)

✓

Technicals

●

MA AlignmentGolden Cross (50D vs 200D +37.4%)

✓

Fundamentals

●

LiquidityCurrent Ratio 0.66 — liquidity risk

✗

Upcoming Events

EEarnings Report · After CloseMay 4, 2026

Tomorrow

DEx-Dividend DateJul 31, 2026

In 89 days

PDividend PaymentOct 28, 2026

In 178 days

Research

Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→

FinancialsFull statements →

Technicals

Market Position

Price Levels

52W High

$367.0+19.1%

Current

$308.1

SMA 50

$302.6-1.8%

SMA 200

$220.2-28.5%

52W Low

$92.01-70.1%

52-Week RangeNear 52-week high

$92.0179th %ile$367.0

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

PFOCUS.NS News

Which Drone Stock Will Dominate the Next War: AVAV, KTOS, or ONDS?

The “Two Popes” Fed: Why the Warsh-Powell Drama Could Burn Your Retirement Nest Egg

Bank of America: How I Double The Average Dividend Yield

8 billionaires who fled California before the “Wealth Tax” hit — and one who didn't

2 Stocks to Watch as the Quantum Space Gets More Crowded

Dynex Capital May Continue To Disappoint

AGNC Is Yielding 13%, And Top Rated: We Predict A Dividend Hike In 2027

Is B&G Foods Stock a Long-Term Buy?

Elon's Terafab Is Moving at “Light Speed” — and That Could Mean Big Things for Tesla

Universal Logistic Holdings Is Surviving By Underinvesting, But Needs A Quick Turn

AMD: Cooling My Rating, Not My Conviction

Blue Owl: No Distress Detected

S&P 500 profits haven't been this rich in at least 15 years — but there's more to the story

This Is the Hottest Stock in the Energy Sector. Should You Invest?

Donald Trump's Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT' Meme Stock Have Watched Billions Evaporate

Twilio: A Well-Deserved Rerating, Here's When I'll Buy Next

Nuveen Core Equity Alpha Fund: Collect An 8% Yield From The Expansion Of The AI Market

Merck: 'Strong Buy' - Terns Acquisition And Ability To Counter Keytruda Patent Loss

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Trump's Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs

About

Explore More